Transcatheter aortic valve-in-valve-in-valve implantation for a failed xenograft

Ann Thorac Surg. 2012 Feb;93(2):647-50. doi: 10.1016/j.athoracsur.2011.07.020.

Abstract

A 78-year-old gentleman with a diagnosis of symptomatic severe xenograft aortic stenosis with multiple comorbidities was referred for transcatheter aortic valve implantation, that is, a "valve-in-valve" procedure. Transcatheter aortic valve implantation was performed by transapical approach using a balloon-expandable bioprosthesis. During valve deployment, the prosthesis moved toward the left ventricle and a second balloon-expandable valve was implanted within the first one-a "valve-in-valve-in-valve" to avoid further ventricular embolization of the first bioprosthesis. Echocardiography at hospital discharge showed a residual mean transvalvular gradient of 17 mm Hg and trivial paravalvular aortic regurgitation. At 1 year follow-up, the patient was in New York Heart Association functional class II.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Angioplasty, Balloon, Coronary
  • Aortic Valve / surgery*
  • Aortic Valve Insufficiency / diagnostic imaging
  • Aortic Valve Stenosis / surgery*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy
  • Bioprosthesis
  • Contraindications
  • Coronary Restenosis / therapy
  • Drug-Eluting Stents
  • Endovascular Procedures / methods*
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation / methods*
  • Humans
  • Internal Mammary-Coronary Artery Anastomosis
  • Male
  • Postoperative Complications / diagnostic imaging
  • Prosthesis Design
  • Radiography, Interventional
  • Recurrence
  • Reoperation / methods
  • Sternotomy
  • Ultrasonography

Substances

  • Adrenal Cortex Hormones